FDA Peptide Reclassification 2026: What It Means for Patients in Miami
Last updated: June 10, 2026 Quick Answer On April 15, 2026, the FDA removed 12 peptides from Category 2, a classification that had previously restricted their compounding due to safety concerns. This does not mean these peptides are immediately available for compounding, but it is a significant step toward restoring access for patients in Miami…